Evidence map›Paper›PMID 42521812›Full record

ReviewEuropean journal of human genetics : EJHG2026

Lived experiences in rare genetic diseases: a narrative synthesis of 317 qualitative studies (2004-2024).

Marianne Gush, Shahida Moosa

Abstract readReview
PubMed Publisher
In one paragraph

Review in European journal of human genetics : EJHG, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Marianne GushDivision of Molecular Biology and Human Genetics, Stellenbosch University, Cape Town, South Africa. mgush@sun.ac.za.ORCID http://orcid.org/0000-0001-6293-4253
Shahida MoosaDivision of Molecular Biology and Human Genetics, Stellenbosch University, Cape Town, South Africa.ORCID http://orcid.org/0000-0002-4463-3067

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rare genetic diseases (RDs), though individually uncommon, collectively impose a substantial global burden with significant social, emotional and economic implications. Understanding the lived experiences of RD patients, caregivers and service providers is essential to fully address the challenges they face. This study presents a narrative synthesis of original qualitative research on RDs published between 2004 and 2024, identifying 317 studies across multiple databases. Reflexive thematic analysis was used to synthesise and interpret the findings, allowing for an integrative understanding of both commonalities and disparities in experiences and research focus globally. While studies from Europe (45%) and North America (32%) dominated the field, markedly fewer included participants from Africa (3%), Asia (11%) and South America (2%), particularly from low- to middle-income countries. Across studies, recurring themes included navigating emotional resilience; the redefinition of identity in the face of RD; the social experience of illness; healthcare experiences, including access to and quality of healthcare services; the financial and logistical burden of care; the experience of research and new technologies; and the influence of society, culture and power structures. The pronounced underrepresentation of LMIC settings, persisting despite targeted search efforts, is itself a substantive finding, raising critical questions about where rare disease knowledge is produced and whose experiences are considered worthy of formal documentation. The synthesis underscores the urgent need for geographically inclusive, methodologically diverse and community-engaged approaches to qualitative RD research.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.